Article Details
Retrieved on: 2021-03-16 20:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In January 2021, AVEO announced that its Investigational New Drug (IND) application for AV-380, a potent humanized IgG1 monoclonal antibody that ...
Article found on: www.cadillacnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here